TGFB1 and neoplasm: In either 2- or 3-dimensional assays in vitro, CAR-modified NK-92 cells can overcome the major challenges of TME, including hypoxic conditions, immunosuppressive molecules such as TGF-β, and an acidic pH environment, thus successfully migrating and infiltrating into the tumor site and specifically dissolved MM cell lines [118].